gene therapy News

BioResearch Open Access, a new bimonthly peer-reviewed open access journal, will launch in March 2012 by Mary Ann Liebert, Inc., publishers (www.liebertpub.com).

The time for commercial development of gene therapy has come. Patients with diseases treatable and curable with gene therapy deserve access to the technology.

The genetic test will be available to eye doctors by the end of 2011. Applying gene therapy to humans in a FDA monitored clinical trial is planned.

The future of fighting the AIDS epidemic and possibly leading to HIV eradication rests on two new approaches. Drugs that activate the latent cells and gene therapy are the two new possible strategies in the future fight against the disease.

The rising number of research & development work around the world will boost the global Gene Therapy market to new heights, says RNCOS in its latest research.

Scientific advances towards an HIV cure will be the main topic of the second day of the "International Symposium on HIV & Emerging Infectious Diseases".

Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body

Results of Poll on Gene Therapy Net. More than 60% of the people are of the opinion that gene therapy will be a vital part of future health care.

Failure of Conventional Therapies in Curing Chronic Diseases has Created High-unmet Needs

Give caffeine to cells engineered to produce viruses used for gene therapy and the cells can generate 3- to 8-times more virus, according to a paper published in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

A new, simplified method for producing large amounts of viral vector cassettes capable of shuttling genes into host cells will help advance the promising field of gene therapy as applications move into large animal studies and human clinical trials.

The introduction of a new, fully characterized viral vector for use as reference material to help standardize gene therapy protocols in research applications and human clinical trials is described in an article in Human Gene Therapy

Synpromics announces its incorporation as Scotland’s latest biotech company. The new company aims to focus its activities in the area of synthetic biology and has acquired its patents from its managing director; Dr Michael Roberts.

Richmond-based FightSMA announced today a new fundraising campaign for spinal muscular atrophy gene therapy, “Realizing the Dream.”

Up-to-date on-stop information on gene therapy with 72 tables and 13 figures

Molecular Therapy, the journal of the American Society of Gene & Cell Therapy, has its research cited up to twice as often as other journals in the field, according to new Thompson Reuters reports.

The Louisiana Gene Therapy Research Consortium celebrates 10 years of providing new hope for people with serious inherited and acquired diseases by helping Louisiana scientists discover successful cell and gene therapies.

The Gene Therapy Review announces both the release of its first print edition, featuring all the educational articles submitted to the genetherapyreview.com website, and its partnership with EBSCO publishing.

The American Society of Gene & Cell Therapy (ASGCT) Board of Directors recently unveiled a new mission statement and goals for ASGCT, as well as a new logo and website domain for the Society.

Gene Therapy Net is pleased to announce the launch of a gene therapy quiz in combination with an in depth review of the concept behind gene therapy in order to boost awareness.

Gene therapy should be used in tandem with stem cell therapy to enhance the reliability and efficacy of stem cells, according to research presented at the American Society of Gene Therapy’s 12th Annual Meeting, May 30.

Stem cells containing protective genes may provide permanent control of human immunodeficiency virus (HIV) in infected individuals, according to research presented at the American Society of Gene Therapy 12th Annual Meeting, May 30.

A herpes virus better known for causing cold sores has shown promise as a treatment for late-stage skin cancer, according to research presented at the American Society of Gene Therapy’s 12th Annual Meeting, May 27.

In the past 20 years, gene therapy has advanced from concept to effective clinical application, according to a presentation at the American Society of Gene Therapy’s 12th Annual Meeting, May 27.

GenScript offers low-endotoxin plasmids in a selection of quantities.

Researchers experience that it is hard to keep up with new gene therapy developments. With the launch of a new online portal this year, relevant gene therapy information is now collected on a comprehensive website.

Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children.

Neuro-Oncology: The Essentials successfully delivers the essence of neuro-oncology in an attractive, user-friendly format. The new edition is an invaluable reference tool for neurosurgeons, neurologists, oncologists, residents as well as students.

RNAi represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing applications of RNAi and microRNAs will begin in Human Gene Therapy.

Can a patient who agrees to participate in a study of a gene therapy protocol give informed consent and understand the risks when the consent forms are highly technical and the physician or institution seeking their consent has a stake in the study?